These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11454011)

  • 21. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity.
    Carr MC; Hokanson JE; Zambon A; Deeb SS; Barrett PH; Purnell JQ; Brunzell JD
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2831-7. PubMed ID: 11397895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.
    Kaufmann PA; Gnecchi-Ruscone T; Schäfers KP; Lüscher TF; Camici PG
    J Am Coll Cardiol; 2000 Jul; 36(1):103-9. PubMed ID: 10898420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of dietary fat intake and the hepatic lipase -480C-->T polymorphism in determining hepatic lipase activity: the Hoorn Study.
    Bos G; Dekker JM; Feskens EJ; Ocke MC; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ; Jansen H
    Am J Clin Nutr; 2005 Apr; 81(4):911-5. PubMed ID: 15817871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
    Tahvanainen E; Syvanne M; Frick MH; Murtomaki-Repo S; Antikainen M; Kesaniemi YA; Kauma H; Pasternak A; Taskinen MR; Ehnholm C
    J Clin Invest; 1998 Mar; 101(5):956-60. PubMed ID: 9486964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease.
    Taqueti VR; Shaw LJ; Cook NR; Murthy VL; Shah NR; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
    Circulation; 2017 Feb; 135(6):566-577. PubMed ID: 27881570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The -514 C/T polymorphism in the hepatic lipase gene promoter is associated with insulin sensitivity in a healthy young population.
    Gómez P; Pérez-Jiménez F; Marín C; Moreno JA; Gómez MJ; Bellido C; Pérez-Martínez P; Fuentes F; Paniagua JA; López-Miranda J
    J Mol Endocrinol; 2005 Apr; 34(2):331-8. PubMed ID: 15821100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between -514C-->T polymorphism of the hepatic lipase gene and coronary artery disease in a Turkish population.
    Gündoğdu F; Gurlertop Y; Pirim I; Aksakal E; Dogan H; Islamoglu Y; Ozkan A; Senocak H
    Acta Cardiol; 2008 Apr; 63(2):197-202. PubMed ID: 18468200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity.
    Beanlands RS; Muzik O; Melon P; Sutor R; Sawada S; Muller D; Bondie D; Hutchins GD; Schwaiger M
    J Am Coll Cardiol; 1995 Nov; 26(6):1465-75. PubMed ID: 7594072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.
    Hegele RA; Harris SB; Brunt JH; Young TK; Hanley AJ; Zinman B; Connelly PW
    Atherosclerosis; 1999 Sep; 146(1):153-60. PubMed ID: 10487498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary reactivity, homocysteine and methylenetetrahydrofolate reductase gene variation in young men during pravastatin therapy.
    Nieminen T; Knuuti J; Hämelahti P; Kähönen M; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Jokela H; Lehtimäki T
    Vascul Pharmacol; 2007; 47(2-3):113-7. PubMed ID: 17574929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.
    Talmud PJ; Hawe E; Robertson K; Miller GJ; Miller NE; Humphries SE
    Ann Hum Genet; 2002 Mar; 66(Pt 2):111-24. PubMed ID: 12174215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel polymorphism A(+884)-->G in the hepatic lipase gene and its association with coronary artery disease.
    Su ZG; Zhang SZ; Zhang L; Tong Y; Xiao CY; Hou YP; Liao LC
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):606-10. PubMed ID: 12883629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults.
    Janatuinen T; Laaksonen R; Vesalainen R; Raitakari O; Lehtimäki T; Nuutila P; Knuuti J
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):561-8. PubMed ID: 11588526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease.
    Gupta A; Taqueti VR; van de Hoef TP; Bajaj NS; Bravo PE; Murthy VL; Osborne MT; Seidelmann SB; Vita T; Bibbo CF; Harrington M; Hainer J; Rimoldi O; Dorbala S; Bhatt DL; Blankstein R; Camici PG; Di Carli MF
    Circulation; 2017 Dec; 136(24):2325-2336. PubMed ID: 28864442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population.
    Inazu A; Nishimura Y; Terada Y; Mabuchi H
    J Hum Genet; 2001; 46(4):172-7. PubMed ID: 11322655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults.
    Laaksonen R; Janatuinen T; Vesalainen R; Lehtimäki T; Elovaara I; Jaakkola O; Jokela H; Laakso J; Nuutila P; Punnonen K; Raitakari O; Saikku P; Salminen K; Knuuti J
    Eur J Clin Invest; 2002 Nov; 32(11):795-802. PubMed ID: 12423319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study.
    Ordovas JM; Corella D; Demissie S; Cupples LA; Couture P; Coltell O; Wilson PW; Schaefer EJ; Tucker KL
    Circulation; 2002 Oct; 106(18):2315-21. PubMed ID: 12403660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study.
    Pöllänen PJ; Karhunen PJ; Mikkelsson J; Laippala P; Perola M; Penttilä A; Mattila KM; Koivula T; Lehtimäki T
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1446-50. PubMed ID: 11557670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.